![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Bayer HealthCare’s Betaconnect
FDA Approves Bayer HealthCare’s Betaconnect
![](https://www.fdanews.com/ext/resources/test/Drug-Images/bayer.gif?t=1443460815&width=430)
The FDA has approved Bayer HealthCare’s Betaconnect, an electronic autoinjector for the treatment of relapsing-remitting multiple sclerosis.
Betaconnect will be available in early 2016 to patients taking Betaseron, a drug used to reduce the number of relapses in people with relapsing forms of MS.
The device offers customizable injection speed and depth settings at the push of a button. Patients can inject the drug quietly and with precision, the Leverkusen, Germany, drugmaker says.
The device is also equipped with automatic needle insertion and retraction and visual and audio end-of-dose indication, which lets patients know when the injection is complete. — Michael Cipriano
Upcoming Events
-
21Oct